Carole A Oskeritzian1, Nitai C Hait2, Piper Wedman3, Alena Chumanevich3, Elizabeth M Kolawole4, Megan M Price2, Yves T Falanga4, Kuzhuvelil B Harikumar2, John J Ryan4, Sheldon Milstien2, Roger Sabbadini5, Sarah Spiegel2. 1. Department of Pathology, Microbiology and Immunology, University of South Carolina School of Medicine, Columbia, SC; Department of Biochemistry and Molecular Biology, Virginia Commonwealth University School of Medicine, Richmond, Va. Electronic address: Carole.Oskeritzian@uscmed.sc.edu. 2. Department of Biochemistry and Molecular Biology, Virginia Commonwealth University School of Medicine, Richmond, Va. 3. Department of Pathology, Microbiology and Immunology, University of South Carolina School of Medicine, Columbia, SC. 4. Department of Biology, Virginia Commonwealth University, Richmond, Va. 5. Lpath, San Diego, Calif.
Abstract
BACKGROUND: Sphingosine-1-phosphate (S1P) is a bioactive sphingolipid produced by mast cells (MCs) on cross-linking of their high-affinity receptors for IgE by antigen that can amplify MC responses by binding to its S1P receptors. An acute MC-dependent allergic reaction can lead to systemic shock, but the early events of its development in lung tissues have not been investigated, and S1P functions in the onset of allergic processes remain to be examined. OBJECTIVE: We used a highly specific neutralizing anti-S1P antibody (mAb) and the sphingosine-1-phosphate receptor 2 (S1PR2) antagonist JTE-013 to study the signaling contributions of S1P and S1PR2 to MC- and IgE-dependent airway allergic responses in mice within minutes after antigen challenge. METHODS: Allergic reaction was triggered by a single intraperitoneal dose of antigen in sensitized mice pretreated intraperitoneally with anti-S1P, isotype control mAb, JTE-013, or vehicle before antigen challenge. RESULTS: Kinetics experiments revealed early pulmonary infiltration of mostly T cells around blood vessels of sensitized mice 20 minutes after antigen exposure. Pretreatment with anti-S1P mAb inhibited in vitro MC activation, as well as in vivo development of airway infiltration and MC activation, reducing serum levels of histamine, cytokines, and the chemokines monocyte chemoattractant protein 1/CCL2, macrophage inflammatory protein 1α/CCL3, and RANTES/CCL5. S1PR2 antagonism or deficiency or MC deficiency recapitulated these results. Both in vitro and in vivo experiments demonstrated MC S1PR2 dependency for chemokine release and the necessity for signal transducer and activator of transcription 3 activation. CONCLUSION: Activation of S1PR2 by S1P and downstream signal transducer and activator of transcription 3 signaling in MCs regulate early T-cell recruitment to antigen-challenged lungs through chemokine production.
BACKGROUND:Sphingosine-1-phosphate (S1P) is a bioactive sphingolipid produced by mast cells (MCs) on cross-linking of their high-affinity receptors for IgE by antigen that can amplify MC responses by binding to its S1P receptors. An acute MC-dependent allergic reaction can lead to systemic shock, but the early events of its development in lung tissues have not been investigated, and S1P functions in the onset of allergic processes remain to be examined. OBJECTIVE: We used a highly specific neutralizing anti-S1P antibody (mAb) and the sphingosine-1-phosphate receptor 2 (S1PR2) antagonist JTE-013 to study the signaling contributions of S1P and S1PR2 to MC- and IgE-dependent airway allergic responses in mice within minutes after antigen challenge. METHODS:Allergic reaction was triggered by a single intraperitoneal dose of antigen in sensitized mice pretreated intraperitoneally with anti-S1P, isotype control mAb, JTE-013, or vehicle before antigen challenge. RESULTS: Kinetics experiments revealed early pulmonary infiltration of mostly T cells around blood vessels of sensitized mice 20 minutes after antigen exposure. Pretreatment with anti-S1P mAb inhibited in vitro MC activation, as well as in vivo development of airway infiltration and MC activation, reducing serum levels of histamine, cytokines, and the chemokines monocyte chemoattractant protein 1/CCL2, macrophage inflammatory protein 1α/CCL3, and RANTES/CCL5. S1PR2 antagonism or deficiency or MC deficiency recapitulated these results. Both in vitro and in vivo experiments demonstrated MCS1PR2 dependency for chemokine release and the necessity for signal transducer and activator of transcription 3 activation. CONCLUSION: Activation of S1PR2 by S1P and downstream signal transducer and activator of transcription 3 signaling in MCs regulate early T-cell recruitment to antigen-challenged lungs through chemokine production.
Keywords:
Airway inflammation; T cells; allergy; mast cells; recruitment; signal transducer and activator of transcription 3; sphingosine-1-phosphate; sphingosine-1-phosphate receptor 2
Authors: Harry Karmouty-Quintana; Sana Siddiqui; Muhannad Hassan; Kimitake Tsuchiya; Paul-Andre Risse; Laura Xicota-Vila; Maria Marti-Solano; James G Martin Journal: Am J Physiol Lung Cell Mol Physiol Date: 2012-01-27 Impact factor: 5.464
Authors: Jiehui Deng; Yong Liu; Heehyoung Lee; Andreas Herrmann; Wang Zhang; Chunyan Zhang; Shudan Shen; Saul J Priceman; Maciej Kujawski; Sumanta K Pal; Andrew Raubitschek; Dave S B Hoon; Stephen Forman; Robert A Figlin; Jie Liu; Richard Jove; Hua Yu Journal: Cancer Cell Date: 2012-05-15 Impact factor: 31.743
Authors: Andrea M Siegel; Kelly D Stone; Glenn Cruse; Monica G Lawrence; Ana Olivera; Mi-yeon Jung; John S Barber; Alexandra F Freeman; Steven M Holland; Michelle O'Brien; Nina Jones; Celeste G Nelson; Laura B Wisch; Heidi H Kong; Avanti Desai; Orly Farber; Alasdair M Gilfillan; Juan Rivera; Joshua D Milner Journal: J Allergy Clin Immunol Date: 2013-11-01 Impact factor: 10.793
Authors: Mohit Kashyap; Angela M Thornton; Sarah Kennedy Norton; Brian Barnstein; Matthew Macey; Jennifer Brenzovich; Ethan Shevach; Warren J Leonard; John J Ryan Journal: J Immunol Date: 2008-02-15 Impact factor: 5.422
Authors: Jason C Kovacic; Rohit Gupta; Angela C Lee; Mingchao Ma; Fang Fang; Claire N Tolbert; Avram D Walts; Leilani E Beltran; Hong San; Guibin Chen; Cynthia St Hilaire; Manfred Boehm Journal: J Clin Invest Date: 2009-12-28 Impact factor: 14.808
Authors: Puneet S Jolly; Meryem Bektas; Ana Olivera; Claudia Gonzalez-Espinosa; Richard L Proia; Juan Rivera; Sheldon Milstien; Sarah Spiegel Journal: J Exp Med Date: 2004-04-05 Impact factor: 14.307
Authors: Yamila I Rodriguez; Ludmila E Campos; Melina G Castro; Ahmed Aladhami; Carole A Oskeritzian; Sergio E Alvarez Journal: Front Oncol Date: 2016-10-17 Impact factor: 6.244
Authors: Kira V Blankenbach; Stephanie Schwalm; Josef Pfeilschifter; Dagmar Meyer Zu Heringdorf Journal: Front Pharmacol Date: 2016-06-21 Impact factor: 5.810